Letter to the Editor: Benchmarking clinical risk prediction algorithms with ensemble machine learning for the noninvasive diagnosis of liver fibrosis in NAFLD.
作者信息
Yang Yanfei, Luo Xu, Cui Shimeng, Lin Zhikun
机构信息
Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
出版信息
Hepatology. 2025 Jan 1;81(1):E10-E11. doi: 10.1097/HEP.0000000000001094. Epub 2024 Sep 18.
Abstract
摘要
相似文献
1
Letter to the Editor: Benchmarking clinical risk prediction algorithms with ensemble machine learning for the noninvasive diagnosis of liver fibrosis in NAFLD.致编辑的信：使用集成机器学习对非酒精性脂肪性肝病（NAFLD）肝纤维化进行无创诊断的临床风险预测算法基准测试
Hepatology. 2025 Jan 1;81(1):E10-E11. doi: 10.1097/HEP.0000000000001094. Epub 2024 Sep 18.
2
Benchmarking clinical risk prediction algorithms with ensemble machine learning for the noninvasive diagnosis of liver fibrosis in NAFLD.利用集成机器学习对非酒精性脂肪性肝病（NAFLD）肝纤维化进行无创诊断的临床风险预测算法的基准测试
Hepatology. 2024 Nov 1;80(5):1184-1195. doi: 10.1097/HEP.0000000000000908. Epub 2024 Apr 30.
3
Noninvasive Diagnosis of Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis Using Machine Learning Methods: Comparative Study With Existing Quantitative Risk Scores.使用机器学习方法对非酒精性脂肪性肝炎和晚期肝纤维化进行无创诊断：与现有定量风险评分的比较研究
JMIR Med Inform. 2022 Jun 6;10(6):e36997. doi: 10.2196/36997.
4
Benchmarking clinical risk prediction algorithms with ensemble machine learning: An illustration of the superlearner algorithm for the non-invasive diagnosis of liver fibrosis in non-alcoholic fatty liver disease.使用集成机器学习对临床风险预测算法进行基准测试：非酒精性脂肪性肝病中肝纤维化无创诊断的超学习器算法示例
medRxiv. 2023 Aug 4:2023.08.02.23293569. doi: 10.1101/2023.08.02.23293569.
5
Precision Non-Alcoholic Fatty Liver Disease (NAFLD) Diagnosis: Leveraging Ensemble Machine Learning and Gender Insights for Cost-Effective Detection.精准非酒精性脂肪性肝病（NAFLD）诊断：利用集成机器学习和性别见解进行经济高效的检测
Bioengineering (Basel). 2024 Jun 12;11(6):600. doi: 10.3390/bioengineering11060600.
6
Benchmarking ensemble machine learning algorithms for multi-class, multi-omics data integration in clinical outcome prediction.用于临床结局预测中多类别、多组学数据整合的基准集成机器学习算法
Brief Bioinform. 2025 Mar 4;26(2). doi: 10.1093/bib/bbaf116.
7
Machine Learning Models for Predicting Significant Liver Fibrosis in Patients with Severe Obesity and Nonalcoholic Fatty Liver Disease.用于预测重度肥胖和非酒精性脂肪性肝病患者显著肝纤维化的机器学习模型
Obes Surg. 2024 Dec;34(12):4393-4404. doi: 10.1007/s11695-024-07548-z. Epub 2024 Oct 25.
8
Training of computational algorithms to predict NAFLD activity score and fibrosis stage from liver histopathology slides.训练计算算法，以从肝组织病理学幻灯片预测非酒精性脂肪性肝病活动评分和纤维化分期。
Comput Methods Programs Biomed. 2021 Aug;207:106153. doi: 10.1016/j.cmpb.2021.106153. Epub 2021 May 8.
9
Blood Glucose Level Prediction: Advanced Deep-Ensemble Learning Approach.血糖水平预测：先进的深度集成学习方法。
IEEE J Biomed Health Inform. 2022 Jun;26(6):2758-2769. doi: 10.1109/JBHI.2022.3144870. Epub 2022 Jun 3.
10
Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future.非酒精性脂肪性肝病肝纤维化的无创性血清标志物：现状与展望。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S157-S170. doi: 10.3350/cmh.2022.0348. Epub 2022 Nov 22.
本文引用的文献
1
Deep learning and digital pathology powers prediction of HCC development in steatotic liver disease.深度学习与数字病理学助力预测脂肪性肝病中肝癌的发展。
Hepatology. 2025 Mar 1;81(3):976-989. doi: 10.1097/HEP.0000000000000904. Epub 2024 May 20.
2
Benchmarking clinical risk prediction algorithms with ensemble machine learning for the noninvasive diagnosis of liver fibrosis in NAFLD.利用集成机器学习对非酒精性脂肪性肝病（NAFLD）肝纤维化进行无创诊断的临床风险预测算法的基准测试
Hepatology. 2024 Nov 1;80(5):1184-1195. doi: 10.1097/HEP.0000000000000908. Epub 2024 Apr 30.
3
Combined model integrating deep learning, radiomics, and clinical data to classify lung nodules at chest CT.联合深度学习、影像组学和临床数据的模型用于在胸部 CT 上对肺结节进行分类。
Radiol Med. 2024 Jan;129(1):56-69. doi: 10.1007/s11547-023-01730-6. Epub 2023 Nov 16.
4
Functional Outcome Prediction After Spinal Cord Injury Using Ensemble Machine Learning.基于集成机器学习的脊髓损伤后功能预后预测。
Arch Phys Med Rehabil. 2024 Jan;105(1):95-100. doi: 10.1016/j.apmr.2023.08.011. Epub 2023 Sep 14.
Zotero 插件